Innovation in CRC Research: Targeting SPACA6P‐AS for Progression

Tianyi Ma,Yinghu Jin,Song Wang,Hanqing Hu,Meng Wang,Guoqing Yan,Qingchao Tang,Rui Huang,Guiyu Wang
DOI: https://doi.org/10.1002/jbt.70039
IF: 3.568
2024-12-12
Journal of Biochemical and Molecular Toxicology
Abstract:ABSTRACT The purpose of this research was to provide light on the functional role that the long noncoding RNA SPACA6P‐AS plays in the biology of colorectal cancer (CRC). The presence of elevated SPACA6P‐AS expression in colorectal cancer tissues is linked to advanced stages of the disease as well as a decreased overall survival rate. It has been demonstrated through knockdown tests conducted on CRC cell lines that SPACA6P‐AS stimulates cell growth in both in vitro and in vivo settings. By acting as a competing endogenous RNA, SPACA6P‐AS is able to modulate the levels of miR‐339‐5p and promote the proliferation of colorectal cancer cells by way of the miR‐339‐5p/FAM167AFAM167A signaling axis. Based on these findings, SPACA6P‐AS is a promising candidate for both a prognostic marker and a therapeutic target in colorectal cancer.
biochemistry & molecular biology,toxicology
What problem does this paper attempt to address?